Red X iconGreen tick iconYellow tick icon

Contact Details

+64 3 474 0999 extn 58567
Professor and Head of Department
Department of Women's and Children's Health (Dunedin)
MB BS(Hons)Queensland PhD Sydney DMedSc FRACP FAFPHM
Research summary
Epidemiology of vaccine-preventable diseases. Use of big data (disease and immunisation coverage registers). Vaccine trials.
Supervised multiple students at honours', masters' and PhD level, advanced trainees in paediatrics and public health medicine. Summer student won Gil Barbezat prize for Summer Studentship 20/22.
  • Strategic Advisory Group of Experts for the Immunisation, World Health Organisation (Geneva) 2019
  • Member, COVID-19 Vaccine Technical Advisory Group, NZ Ministry of Health
  • Qualified in paediatric infectious diseases and public health medicine
  • Medical Advisor to Immunisation Advisory Centre (IMAC), Auckland


Peter McIntyre, Head of Department, has been a Professor in the Department of Women’s and Children’s Health of the University of Otago since 2018. From 2004 to 2017, he was Director of Australia’s National Centre for Immunisation Research and Surveillance and a Professor in the Discipline of Child and Adolescent Health at the University of Sydney.

His PhD was in the epidemiology and prevention of invasive Hib disease (University of Sydney 1995) and in 2021 he was awarded a Doctor of Medical Science by the University of Sydney for 66 papers on vaccine coverage, impact and effectiveness. His major research interests have been in invasive pneumococcal and meningococcal disease and pertussis and most recently waning immunity to measles for which he is leading a HRC clinical trial commencing in 2023. He is author of more than 450 publications, relating to a wide range of vaccines and vaccine-preventable disease topics.


Leach, A. J., Wilson, N., Arrowsmith, B., Beissbarth, J., Mulholland, K., Santosham, M., … McIntyre, P., … Morris, P. S. (2024). Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS Medicine, 21(6), e1004375. doi: 10.1371/journal.pmed.1004375 Journal - Research Article

Young, A., Hobbs, M., Willing, E., McDonald, G., Dawson, P., Marek, L., Fangupo, L., & McIntyre, P. (2024). Protecting hapu māmā and newborn babies through immunisation during pregnancy in Aotearoa New Zealand. The Briefing, (9 April). Retrieved from Journal - Research Other

Huang, Q. S., Turner, N., Wood, T., Anglemyer, A., McIntyre, P., Aminisani, N., Dowell, T., … Geoghegan, J., … Jelley, L., … Baker, M. G., Kvalsvig, A., … Webby, R. J. (2024). Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand. Influenza & Other Respiratory Viruses, 18, e13247. doi: 10.1111/irv.13247 Journal - Research Article

Leach, A. J., Wilson, N., Arrowsmith, B., Beissbarth, J., Mulholland, E. K., Santosham, M., … McIntyre, P., … Morris, P. S. (2023). Otitis media at 6-monthly assessments of Australian First Nations children between ages 12-36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines. International Journal of Pediatric Otorhinolaryngology, 175, 111776. doi: 10.1016/j.ijporl.2023.111776 Journal - Research Article

Leach, A., Wilson, N., Arrowsmith, B., Beissbarth, J., Mulholland, K., Santosham, M., … McIntyre, P., … Morris, P. (2023). Prevalence of otitis media, hearing impairment and language delay in First Nations children, birth to age 3 years. Australian Journal of General Practice, (Suppl. 2), (pp. 16). Retrieved from Conference Contribution - Published proceedings: Abstract

Back to top